Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 19/20 | 1.00 |
| ▸ | CA1 | P00915 | 10/20 | 1.00 |
| ▸ | CA4 | P22748 | 5/20 | 1.00 |
| ▸ | CA12 | O43570 | 4/20 | 1.00 |
| ▸ | CA5A | P35218 | 3/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 1.00 |
| ▸ | CA9 | Q16790 | 3/20 | 1.00 |
| ▸ | CA6 | P23280 | 2/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CA3 | P07451 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10924391 | 0.94 | CA2 (0.88) | CA2CA1CA4CA12CA5A | |
| SCHEMBL564235 | 0.87 | CA2 (1.00) | CA2CA1CA4CA12CA5A | |
| SCHEMBL5174764 | 0.83 | CA2 (0.91) | CA2CA1CA4CA12CA5A | |
| SCHEMBL9459715 | 0.81 | CA2 (1.00) | CA2CA1CA4CA12CA5A | |
| SCHEMBL10473056 | 0.80 | CA2 (0.69) | CA2CA1CA4CA12CA5A | |
| SCHEMBL2616102 | 0.80 | CA2 (0.69) | CA2CA1CA4CA12CA5A | |
| SCHEMBL10474766 | 0.80 | CA2 (0.69) | CA2CA1CA4CA12CA5A | |
| SCHEMBL10473137 | 0.80 | CA2 (0.69) | CA2CA1CA4CA12CA5A | |
| SCHEMBL10473058 | 0.80 | CA2 (0.68) | CA2CA1CA4CA12CA5A | |
| SCHEMBL11118371 | 0.77 | CA2 (0.80) | CA2CA1CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 673 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023059810-A1 | STENTS AND METHODS OF USE | UNIVERSITY OF CONNECTICUT (US) | 2023-04-13 | — | — | WO | claimed |
| WO-2023044463-A1 | SILK FIBROIN DERIVED BRUSH-LIKE POLYMERS | UNIVERSITY OF CONNECTICUT (US) | 2023-03-23 | — | — | WO | claimed |
| EP-1526869-A1 | COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND A CARBONIC ANHYDRASE INHIBITOR FOR THE TREATMENT OF NEOPLASIA | Pharmacia Corporation (US) | 2005-05-04 | — | — | EP | claimed |
| US-20040067992-A1 | Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia | PHARMACIA CORPORATION | 2004-04-08 | — | — | US | claimed |
| WO-2004014430-A1 | COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND A CARBONIC ANHYDRASE INHIBITOR FOR THE TREATMENT OF NEOPLASIA | PHARMACIA CORPORATION (US) | 2004-02-19 | — | — | WO | claimed |
| US-6313155-B1 | Composition and method for treating macular disorders | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2001-11-06 | — | — | US | claimed |
| EP-0126684-B1 | DRUG DELIVERY SYSTEM UTILIZING THERMOSETTING GELS | MERCK & CO. INC. (US) | 1991-08-28 | — | — | EP | claimed |
| EP-0079269-B1 | HYDROXY-SUBSTITUTED-2-BENZOTHIAZOLESULFONAMIDE FOR THE TOPICAL TREATMENT OF ELEVATED INTRAOCULAR PRESSURE | MERCK & CO. INC. (US) | 1986-05-14 | — | — | EP | claimed |
| EP-0126684-A2 | Drug delivery system utilizing thermosetting gels | MERCK & CO. INC. (US) | 1984-11-28 | — | — | EP | claimed |
| US-4474751-A | SUSTAINED RELEASE USING AN ALKYLENEDIAMINE-MODIFIED ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| US-4386098-A | CARBONIC ANHYDRASE INHIBITOR | MERCK & CO., INC. (US) | 1983-05-31 | — | — | US | claimed |
| EP-0079269-A1 | Hydroxy-substituted-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure | MERCK & CO. INC. (US) | 1983-05-18 | — | — | EP | claimed |
| EP-3129065-B1 | TARGETED DRUG DELIVERY THROUGH AFFINITY BASED LINKERS | AKAMARA THERAPEUTICS INC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260124324-A1 | PHOTOCLICK CHEMISTRY OF SILK FOR TEMPORARY UV TATTOOS | TUFTS COLLEGE (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4734896-A2 | BIOPOLYMER-BASED TYMPANOSTOMY TUBES WITH PROGRAMMABLE, TUNABLE, AND ON-DEMAND DEGRADATION | Trustees Of Tufts College (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4735018-A2 | CENTRIFUGALLY-MOLDED ARTICLES AND METHODS | Trustees Of Tufts College (US) | 2026-05-06 | — | — | EP | disclosed |
| US-4386098-A | CARBONIC ANHYDRASE INHIBITOR | MERCK & CO., INC. (US) | 1983-05-31 | — | — | US | disclosed |
| EP-0079269-A1 | Hydroxy-substituted-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure | MERCK & CO. INC. (US) | 1983-05-18 | — | — | EP | disclosed |
| EP-0070239-A1 | Benzothiazolesulfonamide derivatives, their preparation and ophthalmic compositions containing said derivatives | MERCK & CO. INC. (US) | 1983-01-19 | — | — | EP | disclosed |
| EP-0070239-A1 | Benzothiazolesulfonamide derivatives, their preparation and ophthalmic compositions containing said derivatives | MERCK & CO. INC. (US) | 1983-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040067992-A1 | Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia | CA2, CA1, CA4 | CA2 1/4885CA1 2/4885CA4 3/4885 |
| US-20260124324-A1 | PHOTOCLICK CHEMISTRY OF SILK FOR TEMPORARY UV TATTOOS | PTMS, ITK, MATK | CA2 4601/4885CA1 4842/4885CA4 4312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.